STERIS plc (NYSE:STE) Stock Holdings Trimmed by Farther Finance Advisors LLC

Farther Finance Advisors LLC reduced its position in STERIS plc (NYSE:STE) by 19.9% in the 4th quarter, Holdings Channel reports. The institutional investor owned 2,298 shares of the medical equipment provider’s stock after selling 572 shares during the period. Farther Finance Advisors LLC’s holdings in STERIS were worth $472,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of STE. Human Investing LLC bought a new stake in STERIS in the fourth quarter valued at about $31,000. Anfield Capital Management LLC increased its holdings in STERIS by 100.0% in the fourth quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider’s stock valued at $37,000 after buying an additional 91 shares during the last quarter. Central Pacific Bank Trust Division increased its holdings in STERIS by 65.5% in the fourth quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider’s stock valued at $39,000 after buying an additional 76 shares during the last quarter. Manchester Capital Management LLC increased its holdings in STERIS by 182.7% in the fourth quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider’s stock valued at $44,000 after buying an additional 137 shares during the last quarter. Finally, Quarry LP bought a new stake in STERIS in the third quarter valued at about $67,000. 94.69% of the stock is owned by institutional investors.

Analyst Ratings Changes

STE has been the subject of a number of research reports. JMP Securities restated a “market outperform” rating and issued a $265.00 target price on shares of STERIS in a research note on Thursday, February 6th. Stephens restated an “overweight” rating and issued a $240.00 target price on shares of STERIS in a research note on Thursday, February 6th. Finally, Piper Sandler lifted their target price on STERIS from $260.00 to $265.00 and gave the company an “overweight” rating in a research note on Monday, February 3rd. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat.com, STERIS currently has an average rating of “Moderate Buy” and an average price target of $258.75.

STERIS Stock Performance

Shares of NYSE STE opened at $227.04 on Monday. The company has a current ratio of 2.13, a quick ratio of 1.40 and a debt-to-equity ratio of 0.32. The stock has a 50 day simple moving average of $219.17 and a 200-day simple moving average of $222.38. The company has a market cap of $22.31 billion, a PE ratio of 48.20 and a beta of 0.92. STERIS plc has a 12-month low of $197.82 and a 12-month high of $248.24.

STERIS (NYSE:STE) last issued its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. On average, equities research analysts forecast that STERIS plc will post 9.08 EPS for the current year.

STERIS Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 21st. Stockholders of record on Thursday, February 20th will be given a dividend of $0.57 per share. The ex-dividend date of this dividend is Thursday, February 20th. This represents a $2.28 annualized dividend and a dividend yield of 1.00%. STERIS’s dividend payout ratio is presently 48.41%.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.